Discontinuation of Asthma Inhaler Flovent Leads to Insurance and Supply Issues for Some Patients
-
Flovent, a popular asthma inhaler, was discontinued in the U.S. on Jan 1, 2024 by drug company GSK, though generic versions remain available
-
Some patients are reporting insurance difficulties getting generics covered or face supply issues at pharmacies
-
Generics contain the same medicine as Flovent but cost challenges arise when insurance doesn't cover them
-
If insurance denies coverage, patients can request exceptions or get alternative inhalers like ArmonAir or Arnuity
-
Inhaler type matters - meters dose (MDI) vs dry powder (DPI) - so device switches could impact effectiveness if not used properly